Publication | Closed Access

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Molecular PharmacologyThrombosisCardiovascular DiseaseInitial EfficacyCoronary Artery DiseaseCardiovascular PharmacologyPharmacotherapyAcute Myocardial InfarctionPlatelet AntagonistMedicineCardiologyEmergency MedicineAnesthesiologyMyocardial Infarction